Educational content on VJRegenMed is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2020 | The potential of gene-edited effector cell therapy

Maksim Mamonkin, PhD, Baylor College of Medicine, Houston, TX, discusses gene-edited effector cell therapy, and its potential to improve the outcomes of T-cell therapies. This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).